GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated October 25, 2022, reports a corporate governance update regarding changes to Board Committee membership. The filing does not contain financial results or operational data for a specific reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly an announcement of board committee changes.
Material Changes
Effective October 25, 2022, Dr. Anne Beal has stepped down from the Audit & Risk Committee. She will continue her roles as Chair of the Corporate Responsibility Committee and as a member of the Remuneration and Nomination & Corporate Governance committees.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items.
Key Facts for Investors to Verify
- Dr. Anne Beal's removal from the Audit & Risk Committee effective October 25, 2022.
- Dr. Anne Beal's continued leadership of the Corporate Responsibility Committee.
- Confirmation that this filing contains no financial performance data.